| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |